Cargando…
Correlation of nuclear pIGF-1R/IGF-1R and YAP/TAZ in a tissue microarray with outcomes in osteosarcoma patients
Osteosarcoma (OS) is a genetically diverse bone cancer that lacks a consistent targetable mutation. Recent studies suggest the IGF/PI3K/mTOR pathway and YAP/TAZ paralogs regulate cell fate and proliferation in response to biomechanical cues within the tumor microenvironment. How this occurs and thei...
Autores principales: | Molina, Eric R., Chim, Letitia K., Lamhamedi-Cherradi, Salah-Eddine, Mohiuddin, Sana, McCall, David, Cuglievan, Branko, Krishnan, Sandhya, Porter, Robert W., Ingram, Davis R., Wang, Wei-Lien, Lazar, Alexander J., Scott, David W., Truong, Danh D., Daw, Najat C., Ludwig, Joseph A., Mikos, Antonios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8906536/ https://www.ncbi.nlm.nih.gov/pubmed/35284040 http://dx.doi.org/10.18632/oncotarget.28215 |
Ejemplares similares
-
Targeting the IGF/PI3K/mTOR pathway and AXL/YAP1/TAZ pathways in primary bone cancer
por: Truong, Danh D., et al.
Publicado: (2022) -
Transcriptional activators YAP/TAZ and AXL orchestrate dedifferentiation, cell fate, and metastasis in human osteosarcoma
por: Lamhamedi-Cherradi, Salah-Eddine, et al.
Publicado: (2021) -
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
por: Amin, Hesham M., et al.
Publicado: (2020) -
Disc1 Carrier Mice Exhibit Alterations in Neural pIGF-1Rβ and Related Kinase Expression
por: Sultana, Razia, et al.
Publicado: (2020) -
Understanding sarcoma drug resistance one cell at a time
por: Cherradi-Lamhamedi, Salah-Eddine, et al.
Publicado: (2022)